Ophthalmology
Study shows that the retinal age gap might be a potential biomarker of aging linked to increased mortality risk.
20 Jan, 2022 | 09:04h | UTCRetinal age gap as a predictive biomarker for mortality risk – British Journal of Ophthalmology (link to abstract – $ for full-text)
News Release: Difference between retina’s biological age and person’s real age linked to heightened death risk – BMJ
Commentary on Twitter
Difference between retina’s biological age and person’s real age linked to heightened death risk finds @BMJ_Ophth study https://t.co/TNveo5E77D
— BMJ (@bmj_company) January 19, 2022
Grand Challenges in global eye health: a global prioritization process using Delphi method.
18 Jan, 2022 | 09:15h | UTCRelated podcast: Author interview
Commentary on Twitter
Roughly 2.2 billion people have vision impairment—yet 50% of sight loss is preventable.
In @LancetLongevity, Jacqueline Ramke & colleagues identify the key issues that must be addressed to improve global #EyeHealth in the context of an ageing population.https://t.co/banTov24VX pic.twitter.com/tLSZaUYXhw
— The Lancet (@TheLancet) January 6, 2022
Brief review: The clinician’s guide to p values, confidence intervals, and magnitude of effects.
28 Nov, 2021 | 21:06h | UTCThe clinician’s guide to p values, confidence intervals, and magnitude of effects – Eye (if the link is paywalled, try this one)
Related:
Bayesian interpretation of p values in clinical trials.
Scientists Rise Up Against Statistical Significance
.050 shades of grey in p-value cutoffs
What a nerdy debate about p-values shows about science — and how to fix it – VOX
Big names in statistics want to shake up much-maligned P value – Nature News
‘One-size-fits-all’ threshold for P values under fire – Nature News
Statisticians issue warning over misuse of P values – Nature News
Understanding common misconceptions about p-values – The 20% Statistician
Position Statement: Preoperative Care for Cataract Surgery – “In spite of evidence debunking the utility of testing before cataract surgery, studies suggest that medical testing and the use of medical consultations before cataract surgery continue to increase”.
17 Nov, 2021 | 08:33h | UTC
Commentary on Twitter
Nicely written position paper on preop care for cataract surgery. Addresses the most frequent questions (although actual study data is limited). Basically no tests, continue meds, and proceed in most cases unless recent MI,PCI,VTE,CVA,DKA, or HTN urgency. https://t.co/PLHm1LjhZg
— Steven Cohn, MD (@preopconsult) November 16, 2021
Degree of Myopia and Glaucoma Risk: A Dose-Response Meta-Analysis.
22 Oct, 2021 | 10:17h | UTC
Update and guidance on management of myopia.
26 Aug, 2021 | 08:35h | UTC
How to wear a mask and not fog up your glasses.
5 Aug, 2021 | 08:56h | UTCHow to wear a mask and not fog up your glasses – The Philadelphia Inquirer
Guideline summary: A Multidisciplinary collaborative approach to retinal toxic effects screening for patients taking antimalarials.
2 Aug, 2021 | 00:03h | UTCA Multidisciplinary Collaborative Approach to Retinal Toxic Effects Screening for Dermatology Patients Taking Antimalarials – JAMA Dermatology (free for a limited period)
Original Guidance: Joint Statement: Hydroxychloroquine use with respect to retinal toxicity
Clinical practice guidelines for the medical management of Graves’ orbitopathy.
26 Jul, 2021 | 02:26h | UTC
RCT: Intravitreal ranibizumab vs. aflibercept vs. bevacizumab for macular edema due to central retinal vein occlusion.
15 Jul, 2021 | 09:09h | UTC
Guideline | Hydroxychloroquine and Chloroquine Retinopathy: Recommendations on Monitoring.
6 Jul, 2021 | 10:03h | UTCExecutive summary: Hydroxychloroquine and Chloroquine Retinopathy: Recommendations on Monitoring – Royal College of Ophthalmologists
Review: Virtual consultation for red eye.
30 Jun, 2021 | 10:04h | UTCVirtual consultation for red eye – The BMJ
Commentary on Twitter
Red eye is a common ophthalmic presentation in primary care, accounting for 2 to 3% of the consultations.
How can you safely diagnose and manage patients with acute red eye(s) in a virtual consultation?https://t.co/cn12VYpyuW
— The BMJ (@bmj_latest) June 29, 2021
Pragmatic RCT: Among patients with advanced glaucoma, primary trabeculectomy resulted in similar quality of life and safety outcomes and achieved a lower intraocular pressure compared with primary medication.
17 May, 2021 | 08:06h | UTC
Update on Corneal Transplant in 2021
20 Apr, 2021 | 05:33h | UTCUpdate on Corneal Transplant in 2021 – JAMA (free for a limited period)
Study: Teprotumumab for patients with active thyroid eye disease
20 Apr, 2021 | 05:25h | UTCTeprotumumab for patients with active thyroid eye disease: a pooled data analysis, subgroup analyses, and off-treatment follow-up results from two randomised, double-masked, placebo-controlled, multicentre trials – The Lancet Diabetes & Endocrinology (link to abstract – $ for full-text)
Study suggests treatment not always needed to prevent vision loss in patients with elevated eye pressure
18 Apr, 2021 | 21:01h | UTCOriginal study: Assessment of Cumulative Incidence and Severity of Primary Open-Angle Glaucoma Among Participants in the Ocular Hypertension Treatment Study After 20 Years of Follow-up – JAMA Ophthalmology (free for a limited period)
Commentary on Twitter
Only 25% of the OHTS participants developed visual field loss over 20 years of follow-up https://t.co/2DV1gr0cbM
— JAMAOphthalmology (@JAMAOphth) April 15, 2021
AHA Scientific Statement: Management of Central Retinal Artery Occlusion
13 Apr, 2021 | 05:10h | UTCCommentaries: Stroke affecting the eye requires immediate treatment, can signal future vascular events – American Heart Association AND AHA Issues Statement on Central Retinal Artery Occlusion – HealthDay
RCT: Effect of intravitreous anti–vascular endothelial growth factor vs. sham treatment for prevention of vision-threatening complications of diabetic retinopathy
6 Apr, 2021 | 01:02h | UTCCommentaries: Preventive treatment reduces diabetic retinopathy complications – NIH News Releases AND Prevention of Severe Nonproliferative Diabetic Retinopathy Progression With More at Stake Than Visual Acuity – JAMA Ophthalmology AND Practicality of Prophylactic Aflibercept to Reduce Diabetic Retinopathy Progression – JAMA Ophthalmology
Author interview: Randomized Trial of Anti-VEGF to Prevent Proliferative Diabetic Retinopathy (PDR) and Diabetic Macular Edema (DME) – JAMA
Commentary on Twitter
In this study, aflibercept injections reduced the development of vision-threating complications; however, through 2 years, preventive treatment did not confer visual acuity benefit compared with observation plus aflibercept if complications developed https://t.co/q4ABSKOMVj
— JAMAOphthalmology (@JAMAOphth) March 30, 2021
RCT: Efficacy and safety of a dexamethasone intracanalicular insert in patients with allergic conjunctivitis
5 Apr, 2021 | 00:54h | UTCPhase 3 Randomized Study of Efficacy and Safety of a Dexamethasone Intracanalicular Insert in Patients With Allergic Conjunctivitis – American Journal of Ophthalmology (link to abstract – $ for full-text)
Systematic review: Lens extraction for chronic angle-closure glaucoma
2 Apr, 2021 | 09:01h | UTCLens extraction for chronic angle-closure glaucoma – Cochrane Library
Systematic review: Laser peripheral iridoplasty for chronic angle closure
2 Apr, 2021 | 09:02h | UTCLaser peripheral iridoplasty for chronic angle closure – Cochrane Library
Systematic review: Lens extraction for chronic angle‐closure glaucoma
26 Mar, 2021 | 08:22h | UTCLens extraction for chronic angle‐closure glaucoma – Cochrane Library
Joint Statement: Hydroxychloroquine use with respect to retinal toxicity
28 Feb, 2021 | 20:41h | UTCCommentary: Societies Agree on Eye Safety for HCQ – MedPage Today (free registration required) AND ACR, medical societies reach consensus on hydroxychloroquine retinopathy – Healio (free registration required)
Commentary on Twitter
🆕 Joint statement on #Hydroxychloroquine use with respect to retinal toxicity 👀 by several #rheumatology and #opthtalmology societies. #ocular #toxicity relates to #HCQ dosage and duration of use and is seen in 4.3% to 13.8% of patients 🔎#Lupus #SLEhttps://t.co/ocFSCmgVsN
— Laurent ARNAUD (@Lupusreference) February 18, 2021
Experts worry screen time during Covid-19 could increase vision problems in kids
23 Feb, 2021 | 01:48h | UTCRelated: Progression of myopia in school-aged children after COVID-19 home confinement – JAMA Ophthalmology
The Lancet Commission on Global Eye Health: Vision Beyond 2020
19 Feb, 2021 | 02:38h | UTCGlobal Eye Health: vision beyond 2020 – The Lancet Global Health
Commentary on Twitter
NEW—Eliminating preventable sight loss could bring economic benefits of US$411 billion a year, unlock human potential & accelerate global development. @LancetGH #GlobalEyeHealth Commission reports on action needed now to deliver key 👁️ health services. https://t.co/aLNmwKVENB pic.twitter.com/u69JFGL2BY
— The Lancet (@TheLancet) February 17, 2021